Imante Lasyte

#EASLCongress 2025. Exciting day presenting new data on liver steatosis in PSC-pushing the boundaries of what we know! #liversky #PSC

08.05.2025 19:36 — 👍 0    🔁 0    💬 0    📌 0

Redirecting

📌Breakthroughs Beyond the Journal by David C. Trampert

Gut bacterial membrane components as pathogenic signalling molecules in PSC-IBD

Full text here👉https://doi.org/10.1016/j.jhep.2024.11.024

Refers to👉https://doi.org/10.1053/j.gastro.2024.06.032

#LiverSky

11.02.2025 10:12 — 👍 3    🔁 2    💬 0    📌 0

Mortality in Autoimmune Liver Disease in Sweden: A Population‐Based Cohort Study of 9,654 Patients Background/Aims Epidemiological data on mortality in autoimmune liver diseases (AILDs) are scarce. We examined all-cause and cancer-related mortality in individuals with AILD from Sweden. Methods ...

!New Publication Alert !

I am glad to share my recent publication in Liver International titled - "Mortality in Autoimmune Liver Disease in Sweden: A Population-Based Cohort Study of 9,654 Patients".
#liversky #GIsky #LiverInt

onlinelibrary.wiley.com/doi/full/10....

22.01.2025 20:19 — 👍 5    🔁 0    💬 0    📌 0

a man and woman in scrubs

Balancing an academic clinical career and parenthood can be challenging! To gain insights on managing both, the authors of our latest Young GI Blog conducted a survey among colleagues.

Check out their discoveries: 🔗 https://bit.ly/40qapt3

#myUEGcommunity

22.01.2025 16:15 — 👍 1    🔁 1    💬 0    📌 0

⚠️ A recent study in patients with cirrhosis and portal hypertension shows that preoperative placement of TIPS is associated with increased postoperative mortality 🤨

doi.org/10.1097/hc9....

#LiverSky #MedSky

04.01.2025 19:10 — 👍 15    🔁 5    💬 4    📌 1

Three must read papers for PhD students. #scisky #PhD #science #research #academicsky

1. The importance of stupidity in scientific research

Open Access
journals.biologists.com/jcs/article/...

24.11.2024 13:54 — 👍 1218    🔁 458    💬 57    📌 80

Medical treatment of primary sclerosing cholangitis: What... : Hepatology ding on local reimbursement policies and physician preference. The difficulty in drug development in PSC is partly related to poor understanding of critical disease processes with failure to identify ...

Variable evidence hampers effective treatment for primary sclerosing cholangitis, yet ongoing trials spark renewed hope for better therapies.

by Karlsen TH, Kaasen Jørgensen K and Bergquist A in Hepatology

#SkyMed
journals.lww.com/hep/abstract...

01.12.2024 14:02 — 👍 3    🔁 1    💬 0    📌 0